Page last updated: 2024-08-26

fotemustine and Metastase

fotemustine has been researched along with Metastase in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's11 (61.11)18.2507
2000's3 (16.67)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grosso, M; Pesce, M; Picasso, V; Queirolo, P; Spagnolo, F; Tornari, E1
Asselain, B; Barillot, E; Bessard, MA; Couturier, J; Dahmani, A; Decaudin, D; Desjardins, L; Donnadieu, MH; Gentien, D; Lantz, O; Laurent, C; Mariani, P; Némati, F; Péguillet, I; Piperno-Neumann, S; Plancher, C; Reyes, C; Robert, D; Roman-Roman, S; Sastre-Garau, X; Saule, S1
Colucci, G; Cramarossa, A; Fistola, E; Giudice, G; Guida, M; Lubello, K; Porcelli, M1
Eigentler, TK; Garbe, C1
Grange, JD; Kodjikian, L; Rivoire, M1
Falkson, CI; Falkson, G; Falkson, HC1
Bureau, B; Célérier, P; Dreno, B; Litoux, P1
Antoine, E; Auclerc, G; Benhammouda, A; Bizzari, JP; Borel, C; Paraiso, D; Petit, T; Rixe, O; Soubrane, C; Weil, M1
Altenhoff, J; Breitbart, EW; Hossfeld, DK; Kowalzick, L; Marseille, A; Mohr, P; Sarkany, M; Stephan, U; Weichenthal, M1
Bassères, N; Bizzari, JP; Bonerandi, JJ; Gérard, B; Grob, JJ; Richard, MA; Zarrour, H1
Becker, JC; Bröcker, EB; Kämpgen, E; Rünger, TM; Terheyden, P1
Gademann, G; Gollnick, H; Ulrich, J1
Bock, M; Deichmann, M; Jäckel, A; Näher, H; Waldmann, V1
Elgren, TE; Hogenkamp, HP; MacFarlan, S; Nelson, LS; Schallreuter, KU; Yan-Sze, I1
Binder, M; Dorffner, R; Glebowski, E; Pehamberger, H; Winkler, A; Wolff, K1
Berger, J; Brassow, FW; Breitbart, EW; Schallreuter, KU; Teichmann, W; Wenzel, E1
Beerblock, K; Bizzari, JP; Deloffre, P; Lokiec, F; Lucas, C1

Reviews

3 review(s) available for fotemustine and Metastase

ArticleYear
[Therapy of malignant melanoma at the stage of distant metastasis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine

2004
[Immunochemotherapy of metastatic uveal melanoma with interferon alfa-2b, interleukin-2 and fotemustine. Case reports and review of the literature].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:10

    Topics: Antineoplastic Agents; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Treatment Outcome; Uveal Neoplasms

1998
[Therapy of metastatic malignant uveal melanoma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoembolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Skin Neoplasms; Time Factors; Uveal Neoplasms

2001

Trials

4 trial(s) available for fotemustine and Metastase

ArticleYear
Phase II trial of fotemustine in patients with metastatic malignant melanoma.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Thrombocytopenia; Treatment Failure

1994
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patients.
    Melanoma research, 1995, Volume: 5, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Remission Induction; Risk; Salvage Therapy; Survival Rate; Treatment Outcome; Vindesine

1995
Fotemustine and interferon alpha2b in metastatic malignant melanoma.
    Journal of cancer research and clinical oncology, 1998, Volume: 124, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Interferon-alpha; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome

1998
Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma.
    Melanoma research, 1998, Volume: 8, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dacarbazine; Humans; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Survival Rate; Tamoxifen

1998

Other Studies

11 other study(ies) available for fotemustine and Metastase

ArticleYear
Treatment of metastatic uveal melanoma with intravenous fotemustine.
    Melanoma research, 2013, Volume: 23, Issue:3

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Rate; Treatment Outcome; Uveal Neoplasms

2013
Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2010, Apr-15, Volume: 16, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Dacarbazine; Female; Gene Expression Profiling; Humans; In Situ Hybridization, Fluorescence; Male; Melanoma; Mice; Mice, SCID; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Oligonucleotide Array Sequence Analysis; Organophosphorus Compounds; Polymorphism, Single Nucleotide; Temozolomide; Tumor Cells, Cultured; Uveal Neoplasms; Xenograft Model Antitumor Assays

2010
High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study.
    Journal of translational medicine, 2010, Nov-10, Volume: 8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Temozolomide

2010
Prolonged survival after resection of liver metastases from uveal melanoma and intra-arterial chemotherapy.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Fatal Outcome; Female; Follow-Up Studies; Hepatectomy; Humans; Injections, Intra-Arterial; Liver Neoplasms; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate; Time Factors; Uveal Neoplasms

2005
[Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
    Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:6-7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Interferon-alpha; Karnofsky Performance Status; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Treatment Outcome

1993
Management of cerebral metastases from malignant melanoma: results of a combined, simultaneous treatment with fotemustine and irradiation.
    Journal of neuro-oncology, 1999, Volume: 43, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Retrospective Studies; Survival Analysis

1999
Ribonucleotide diphosphate reductase from human metastatic melanoma.
    Melanoma research, 1992, Volume: 2, Issue:5-6

    Topics: Antineoplastic Agents; Cell-Free System; Electron Spin Resonance Spectroscopy; Humans; Hydroxyurea; Kinetics; Macromolecular Substances; Melanoma; Models, Structural; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Ribonucleoside Diphosphate Reductase

1992
Fotemustine plus dacarbazine in advanced stage III malignant melanoma.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Leukopenia; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Thrombocytopenia

1992
Positive phase II study in the treatment of advanced malignant melanoma with fotemustine.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Time Factors

1991
[Fotemustine in the treatment of metastatic malignant melanoma. Overall analysis of results].
    Pathologie-biologie, 1990, Volume: 38, Issue:8

    Topics: Antineoplastic Agents; Dacarbazine; Drug Synergism; Drug Therapy, Combination; Humans; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms

1990
[Study of the clinical pharmacokinetics of fotemustine in various tumor indications].
    Bulletin du cancer, 1989, Volume: 76, Issue:10

    Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Male; Melanoma; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds

1989